Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
5 highlights from American Association for Cancer Research conference
Immunotherapy, health disparities, funding cuts among hot topics at annual meeting
Developing adoptive T-cell therapy for ovarian cancer
At the AACR annual meeting, Dr. Kristin Anderson will describe how engineered T cells are able to kill both human and mouse ovarian cancer cells in the lab.
Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
Former VP Biden offers Cancer Moonshot updates, underscores need for research funding
At annual meeting of cancer researchers, Biden shared highlights of cancer effort so far ― and doled out encouragement in midst of threatened cuts to science
With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer
Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma
Deploying an ancient defense to kill cancer
In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug
‘Innovator’ award for new leukemia immunotherapies
Fred Hutch's Dr. Marie Bleakley has received a 2017 Innovative Research Grant in immuno-oncology from Stand Up To Cancer.
Beyond genomics: Using proteomics to target tumors
Dr. Amanda Paulovich, whose lab has a leading role in the Beau Biden Cancer Moonshot, will speak at the AACR annual meeting about her lab’s pioneering methods to measure proteins that serve as tumor markers.
Dr. Philip Greenberg elected to serve on AACR board of directors
T-cell therapy expert to serve from 2017 to 2020
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
Fred Hutch scientists to cover advances in immunotherapy, proteomics at AACR
The American Association for Cancer Research will hold its 110th annual meeting on April 1-5 in Washington, D.C.
Good News: Damian Green awarded $3.2M to test radioimmunotherapy for multiple myeloma ... and more
Celebrating faculty and staff achievements
Dr. Nancy Davidson, former VP Joe Biden and other cancer leaders share insights about disease that touches so many
University of Pennsylvania panel aptly dubbed ‘A Formidable Foe: Cancer in the 21st Century’
Childhood cancer survivor still inspires Fred Hutch researcher
A budding scientist finds his calling in the lab — years after a Hutch internship with the doctor who diagnosed his rare childhood kidney cancer
American Cancer Society awards research professorship to Fred Hutch immunotherapy physician-scientist Dr. Stanley Riddell
Largest nonprofit, non-government cancer research funder pledges support for next-generation immunotherapy research